The interaction between CD200 and CD200R1 is critical for inhibiting microglial activation and localized neuroinflammation during the pathological development of several brain diseases, including Parkinson’s disease, optic nerve crush, and germinal matrix hemorrhage [13–15]. Here, CD200R1 is linked to brain disorder.